Inventor
Riccardo Cortese
Inventor
Rome, IT
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C07KPeptides20%
C12NMicroorganisms or enzymes18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
C40BCombinatorial chemistry3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
Y02ATechnologies for adaptation to climate change3%
A01KAnimal husbandry2%
PatentTitleYear
10,588,961Poxviral vaccines202010,584,355Chimpanzee adenoviral vector-based filovirus vaccines202010,576,143Poxviral vaccines202010,544,192Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof20209,895,431'Simian adenoviral vectors encoding malaria antigen'20189,718,863'Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof'20179,526,777'Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein'20168,142,794'Hepatitis C virus vaccine'20127,928,193'Antigen binding proteins directed against scavenger receptor B1 that inhibit HCV replication'20117,598,362'Hepatitis C virus vaccine'20097,034,108'Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereof'20066,960,558'Method of screening for anti-obesity agents using ciliary neutrophic factor receptor'20056,706,261'Compositions and methods comprising immunogenic muteins of interleukin-6'20046,565,869'Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity'20036,541,210'Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable'20036,528,061'Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions'20036,265,169'Method based on the use of bacteriophages for the detection biological molecules in biological samples'20015,994,083'Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2020Based in Rome, IT· patent location history
2001–2011Patents assigned to ANGELETTI P IST RICHERCHE BIO (7)· patent assignee history
2003Based in Roma, IT· patent location history
2012–2018Patents assigned to COLLOCA STEFANO (4)· patent assignee history
2012–2018Patents assigned to CORTESE RICCARDO (4)· patent assignee history
2012–2017Patents assigned to NICOSIA ALFREDO (3)· patent assignee history
2016–2020Patents assigned to GLAXOSMITHKLINE BIOLOGICALS SA (7)· patent assignee history
2020Based in Basel, CH· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ANGELETTI P IST RICHERCHE BIO | 7 | 2001–2011 |
| GLAXOSMITHKLINE BIOLOGICALS SA | 7 | 2016–2020 |
| COLLOCA STEFANO | 4 | 2012–2018 |
| CORTESE RICCARDOself | 4 | 2012–2018 |
| NICOSIA ALFREDO | 3 | 2012–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Rome, IT | 15 | 1999–2020 |
| Basel, CH | 2 | 2020 |
| Roma, IT | 1 | 2003 |